Literature DB >> 26939791

Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).

Peter J Noy1, Rajeeb K Swain1, Kabir Khan1, Puja Lodhia1, Roy Bicknell2.   

Abstract

C-type lectin family 14, member A (CLEC14A), is a single-pass transmembrane glycoprotein that is overexpressed in tumor endothelial cells, and it promotes sprouting angiogenesis and modulates endothelial function via interactions with extracellular matrix proteins. Here, we show that CLEC14A is cleaved by rhomboid-like protein 2 (RHBDL2), one of 3 catalytic mammalian rhomboid-like (RHBDL) proteases, but that it is not cleaved by RHBDL1 or -3. Site-directed mutagenesis identified the precise site at which RHBDL2 cleaves CLEC14A, and targeted, small interfering RNAs that knockdown endogenous CLEC14A and RHBDL2 in human endothelial cells validated the specificity of CLEC14A shedding by RHBDL2. Loss of endogenous cleaved CLEC14A increased endothelial migration 2-fold, whereas that addition of recombinant cleaved CLEC14A inhibited the sprouting of human and murine endothelial cells 3-fold in several in vitro models. We assessed the in vivo role of cleaved CLEC14A in angiogenesis by using the rodent subcutaneous sponge implant model, and we found that CLEC14A protein inhibited vascular density by >50%. Finally, we show that cleaved CLEC14A binds to sprouting endothelial tip cells. Our data show that the ectodomain of CLEC14A regulates sprouting angiogenesis and suggests a role for RHBDL2 in endothelial function.-Noy, P. J., Swain, R. K., Khan, K., Lodhia, P., Bicknell, R. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2). © FASEB.

Entities:  

Keywords:  antiangiogenic therapy; mmrn2; multimerin 2; rhomboid substrates

Mesh:

Substances:

Year:  2016        PMID: 26939791     DOI: 10.1096/fj.201500122R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

Review 1.  C-type lectin family XIV members and angiogenesis.

Authors:  Supriya Borah; Dileep Vasudevan; Rajeeb K Swain
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

2.  Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.

Authors:  Daniel R Sandoval; Alejandro Gomez Toledo; Chelsea D Painter; Ember M Tota; M Osman Sheikh; Alan M V West; Martin M Frank; Lance Wells; Ding Xu; Roy Bicknell; Kevin D Corbett; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

3.  Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.

Authors:  Sungwoon Lee; Seung-Sik Rho; Hyojin Park; Jeong Ae Park; Jihye Kim; In-Kyu Lee; Gou Young Koh; Naoki Mochizuki; Young-Myeong Kim; Young-Guen Kwon
Journal:  J Clin Invest       Date:  2016-12-19       Impact factor: 14.808

Review 4.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

5.  Membrane Protein Dimerization in Cell-Derived Lipid Membranes Measured by FRET with MC Simulations.

Authors:  Jan Škerle; Jana Humpolíčková; Nicholas Johnson; Petra Rampírová; Edita Poláchová; Monika Fliegl; Jan Dohnálek; Anna Suchánková; David Jakubec; Kvido Strisovsky
Journal:  Biophys J       Date:  2020-03-29       Impact factor: 4.033

Review 6.  Extracellular Matrix, a Hard Player in Angiogenesis.

Authors:  Maurizio Mongiat; Eva Andreuzzi; Giulia Tarticchio; Alice Paulitti
Journal:  Int J Mol Sci       Date:  2016-11-01       Impact factor: 5.923

7.  Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.

Authors:  Taek-Keun Kim; Chang Sik Park; Jihye Jang; Mi Ra Kim; Hee-Jun Na; Kangseung Lee; Hyun Jung Kim; Kyun Heo; Byong Chul Yoo; Young-Myeong Kim; Je-Wook Lee; Su Jin Kim; Eun Sung Kim; Dae Young Kim; Kiweon Cha; Tae Gyu Lee; Sukmook Lee
Journal:  Mol Oncol       Date:  2018-01-26       Impact factor: 6.603

Review 8.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

9.  Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

Authors:  K A Khan; A J Naylor; A Khan; P J Noy; M Mambretti; P Lodhia; J Athwal; A Korzystka; C D Buckley; B E Willcox; F Mohammed; R Bicknell
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

10.  Quantitative proteomics screen identifies a substrate repertoire of rhomboid protease RHBDL2 in human cells and implicates it in epithelial homeostasis.

Authors:  Nicholas Johnson; Jana Březinová; Elaine Stephens; Emma Burbridge; Matthew Freeman; Colin Adrain; Kvido Strisovsky
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.